WallStSmart

Morgan Stanley (MS)vsPowell Max Limited Class A Ordinary Shares (PMAX)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Morgan Stanley generates 167367% more annual revenue ($79.79B vs $47.65M). MS leads profitability with a 25.6% profit margin vs -49.3%. MS earns a higher WallStSmart Score of 72/100 (B).

MS

Strong Buy

72

out of 100

Grade: B

Growth: 7.3Profit: 8.0Value: 5.7Quality: 4.5
Piotroski: 5/9Altman Z: 0.38

PMAX

Hold

49

out of 100

Grade: D+

Growth: 6.0Profit: 4.0Value: 5.0Quality: 6.0
Piotroski: 5/9Altman Z: -1.33

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MS5 strengths · Avg: 9.0/10
Market CapQuality
$283.60B10/10

Mega-cap, among the largest globally

Operating MarginProfitability
39.9%10/10

Strong operational efficiency at 39.9%

Profit MarginProfitability
25.6%9/10

Keeps 26 of every $100 in revenue as profit

P/E RatioValuation
14.3x8/10

Attractively priced relative to earnings

Price/BookValuation
2.8x8/10

Reasonable price relative to book value

PMAX4 strengths · Avg: 9.8/10
Price/BookValuation
0.0x10/10

Reasonable price relative to book value

Operating MarginProfitability
34.3%10/10

Strong operational efficiency at 34.3%

Revenue GrowthGrowth
72.7%10/10

Revenue surging 72.7% year-over-year

Debt/EquityHealth
0.199/10

Conservative balance sheet, low leverage

Areas to Watch

MS2 concerns · Avg: 3.0/10
PEG RatioValuation
1.764/10

Expensive relative to growth rate

Altman Z-ScoreHealth
0.382/10

Distress zone — elevated risk

PMAX4 concerns · Avg: 2.3/10
Market CapQuality
$3.00M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-167.3%2/10

ROE of -167.3% — below average capital efficiency

EPS GrowthGrowth
-78.7%2/10

Earnings declined 78.7%

Altman Z-ScoreHealth
-1.332/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : MS

The strongest argument for MS centers on Market Cap, Operating Margin, Profit Margin. Profitability is solid with margins at 25.6% and operating margin at 39.9%. Revenue growth of 10.8% demonstrates continued momentum.

Bull Case : PMAX

The strongest argument for PMAX centers on Price/Book, Operating Margin, Revenue Growth. Revenue growth of 72.7% demonstrates continued momentum.

Bear Case : MS

The primary concerns for MS are PEG Ratio, Altman Z-Score.

Bear Case : PMAX

The primary concerns for PMAX are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

MS profiles as a mature stock while PMAX is a hypergrowth play — different risk/reward profiles.

PMAX carries more volatility with a beta of 2.17 — expect wider price swings.

PMAX is growing revenue faster at 72.7% — sustainability is the question.

Monitor CAPITAL MARKETS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MS scores higher overall (72/100 vs 49/100), backed by strong 25.6% margins and 10.8% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Morgan Stanley

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Morgan Stanley is an American multinational investment bank and financial services company headquartered at 1585 Broadway in the Morgan Stanley Building, Midtown Manhattan, New York City.

Powell Max Limited Class A Ordinary Shares

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Powell Max Limited Class A Ordinary Shares (PMAX) is an innovative technology firm focused on providing sustainable solutions that meet the needs of a rapidly changing market landscape. Supported by a seasoned management team and a strong financial position, PMAX is well-equipped to capitalize on emerging trends while effectively managing competitive challenges. The company’s dedication to innovation and operational excellence strengthens its diverse product portfolio and reinforces a customer-centric approach, generating lasting value. With strategic initiatives in place, PMAX is poised for a robust growth trajectory, making it an attractive investment opportunity for institutional stakeholders.

Visit Website →

Want to dig deeper into these stocks?